P1.01-62 The Third Generation Irreversible EGFR Inhibitor HS-10296 in Advanced Non-Small Cell Lung Cancer Patients
Year: 2018
Type: article
Source: Journal of Thoracic Oncology
Institutions: Shanghai Chest Hospital, University of Colorado Denver, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, First Affiliated Hospital Zhejiang University, Zhejiang University, Jiangsu Province Hospital, Taipei Veterans General Hospital, Taichung Veterans General Hospital, Taipei Medical University Hospital, Tongji Hospital, Kaohsiung Chang Gung Memorial Hospital, Beverly Hills Cancer Center, National Cheng Kung University Hospital, Hunan Cancer Hospital, Peking University Cancer Hospital, Peking University, University Cancer and Blood Center, Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Sir Run Run Shaw Hospital, University of California San Diego, Moores Cancer Center, Dartmouth–Hitchcock Medical Center, University of Miami, The University of Texas Medical Branch at Galveston, MultiCare Health System, Baptist Health Floyd, China Medical University Hospital, National Taiwan University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2898471859